电针对慢性失眠障碍患者认知功能与睡眠质量的影响及其脑网络机制研究

注册号:

Registration number:

ChiCTR2200060150 

最近更新日期:

Date of Last Refreshed on:

2023-03-12 16:34:43 

注册时间:

Date of Registration:

2022-05-20 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

电针对慢性失眠障碍患者认知功能与睡眠质量的影响及其脑网络机制研究

Public title:

therapeutic effect of electroacupuncture on cognitive function and sleep quality in chronic insomnia patients and its brain network mechanism

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针对慢性失眠障碍患者认知功能与睡眠质量的影响及其脑网络机制研究

Scientific title:

therapeutic effect of electroacupuncture on cognitive function and sleep quality in chronic insomnia patients and its brain network mechanism

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2200006023

申请注册联系人:

温秀云 

研究负责人:

温秀云 

Applicant:

Wen Xiuyun 

Study leader:

Wen Xiuyun 

申请注册联系人电话:

Applicant telephone:

+86 13760740836

研究负责人电话:

Study leader's
telephone:

+86 13760740836

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wxymeddling@163.com

研究负责人电子邮件:

Study leader's E-mail:

wxymeddling@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市番禺区大学城外环东路280号

研究负责人通讯地址:

广东省广州市番禺区大学城外环东路280号

Applicant address:

280 Waihuan Road East, Daxue City, Panyu District, Guangzhou, Guangdong

Study leader's address:

280 Waihuan Road East, Daxue City, Panyu District, Guangzhou, Guangdong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东药科大学

Applicant's institution:

Guangdong Pharmaceutical University

研究负责人所在单位:

广东药科大学

Affiliation of the Leader:

Guangdong Pharmaceutical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

医伦审【2021】第(49)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广东药科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Guangdong Pharmaceutical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-03-09 00:00:00

伦理委员会联系人:

张政

Contact Name of the ethic committee:

Zhang Zheng

伦理委员会联系地址:

广东省广州市越秀区农林下路19号5号楼5209

Contact Address of the ethic committee:

19 Nonglinxia Road, Yuexiu District, Guangzhou, Guangdong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 61321847

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广东药科大学

Primary sponsor:

Guangdong Pharmaceutical University

研究实施负责(组长)单位地址:

广东省广州市番禺区大学城外环东路280号

Primary sponsor's address:

280 Waihuan Road East, Daxue City, Panyu District, Guangzhou, Guangdong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东药科大学

具体地址:

番禺区外环东路280号

Institution
hospital:

Guangdong Pharmaceutical University

Address:

280 Waihuan Road East, Panyu District

经费或物资来源:

国家自然科学基金

Source(s) of funding:

The National Natural Science Foundation

研究疾病:

慢性失眠障碍  

Target disease:

Chronic insomnia disorder

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.运用多学科研究方法与手段,验证慢性失眠障碍患者脑功能网络的拓扑属性特异性存在,探讨慢性失眠障碍患者脑网络变化特征,明确背外侧前额叶区在此病理过程中的变化与作用。 2.揭示电针慢性失眠障碍疗效脑网络机制,寻求与临床评价相结合的电针疗效机制的客观、可视化指标。  

Objectives of Study:

1. Use multidisciplinary research methods and means to verify the specific existence of topological attributes of brain functional network in patients with chronic insomnia disorder, explore the changing characteristics of brain network in patients with chronic insomnia disorder, and identify the changes and effects of dorsolateral prefrontal region in this pathological process. 2. To reveal the brain network mechanism of the therapeutic effect of electroacupuncture on chronic insomnia disorder, and to seek objective and visual indicators of the therapeutic mechanism of electroacupuncture combined with clinical evaluation.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.合并有抑郁症及焦虑症、精神分裂症等严重精神疾患;
2.有自杀倾向患者;
3.有其他系统的严重疾病需要治疗者;
4.睡眠呼吸暂停综合征;
5.针刺穴位处有皮肤破损、过敏等皮肤相关疾患者。

Exclusion criteria:

1. Patients with depression, anxiety disorder, schizophrenia and other serious mental disorders;
2. Patients with suicidal tendencies;
3. Those who have serious diseases of other systems that need treatment;
4. Sleep apnea syndrome;
5. There are skin damage, allergy and other skin-related diseases at the acupuncture point.

研究实施时间:

Study execute time:

From 2022-01-01 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-06-01 00:00:00 To 2024-08-31 00:00:00

干预措施:

Interventions:

组别:

A组

样本量:

40

Group:

group A

Sample size:

干预措施:

电针加安慰药物

干预措施代码:

Intervention:

electric-acupuncture plus comfort drugs

Intervention code:

组别:

B组

样本量:

40

Group:

group B

Sample size:

干预措施:

药物加安慰电针

干预措施代码:

Intervention:

medicine plus electric-acupuncture

Intervention code:

组别:

C组

样本量:

40

Group:

group C

Sample size:

干预措施:

安慰电针加安慰药物

干预措施代码:

Intervention:

sham needle plus comfort drugs

Intervention code:

组别:

失眠患者组(研究一)

样本量:

16

Group:

insomniac group (Study 1)

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

健康受试者组(研究一)

样本量:

16

Group:

healthy group (Study 1)

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东药科大学附属第一医院 

单位级别:

三级甲等 

Institution
hospital:

The First Affiliated Hospital of Guangdong Pharmaceutical University

Level of the institution:

Teritary A

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州市和平骨科医院 

单位级别:

二级甲等 

Institution
hospital:

Guangzhou Heping Orthopedic Hosipital

Level of the institution:

Secondary A

测量指标:

Outcomes:

指标中文名:

脑电数据指标

指标类型:

主要指标

Outcome:

EEG data index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

威斯康星卡片分类测试

指标类型:

次要指标

Outcome:

Wsiconsin card sorting test

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

匹兹堡睡眠质量指数量表

指标类型:

次要指标

Outcome:

Pittsburgh sleep quality index, PSQI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Null

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用SAS9.3统计分析软件的“Proc plan”程序产生研究所需的随机方案。

Randomization Procedure (please state who generates the random number sequence and by what method):

Adopt SAS9.3 the "proc plan" program of statistical analysis software generates the random scheme required for the study.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

公开原始数据日期:2025/05;可与研究者联系索取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

we will shares trial data bdfore May 2022,You can contact the Researcher to obtain the data.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病例记录表采集和管理量表数据,脑电数据采用专用硬盘储存

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The case record form was used to collect and manage the scale data, and the EEG data was stored in a special hard disk

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-05-20 16:48:52